Abstract
Summary
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
LPI (LP Information)' newest research report, the “Bacteriophages Therapy Service Industry Forecast” looks at past sales and reviews total world Bacteriophages Therapy Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Bacteriophages Therapy Service sales for 2023 through 2029. With Bacteriophages Therapy Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacteriophages Therapy Service industry.
This Insight Report provides a comprehensive analysis of the global Bacteriophages Therapy Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bacteriophages Therapy Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bacteriophages Therapy Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacteriophages Therapy Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacteriophages Therapy Service.
The global Bacteriophages Therapy Service market size is projected to grow from US$ 31 million in 2022 to US$ 61 million in 2029; it is expected to grow at a CAGR of 10.0% from 2023 to 2029.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacteriophages Therapy Service market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Lytic
lysogenic
Segmentation by application
Diagnostic
Antimicrobial Drug Discovery
Veterinary medicines
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AmpliPhi Bioscience Corporation
EnBiotix
iNtoDEWorld
Phage International
Fixed Phage limited
Locus Bioscience
Pherecydes Pharma
LPI (LP Information)' newest research report, the “Bacteriophages Therapy Service Industry Forecast” looks at past sales and reviews total world Bacteriophages Therapy Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Bacteriophages Therapy Service sales for 2023 through 2029. With Bacteriophages Therapy Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacteriophages Therapy Service industry.
This Insight Report provides a comprehensive analysis of the global Bacteriophages Therapy Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bacteriophages Therapy Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bacteriophages Therapy Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacteriophages Therapy Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacteriophages Therapy Service.
The global Bacteriophages Therapy Service market size is projected to grow from US$ 31 million in 2022 to US$ 61 million in 2029; it is expected to grow at a CAGR of 10.0% from 2023 to 2029.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacteriophages Therapy Service market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Lytic
lysogenic
Segmentation by application
Diagnostic
Antimicrobial Drug Discovery
Veterinary medicines
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AmpliPhi Bioscience Corporation
EnBiotix
iNtoDEWorld
Phage International
Fixed Phage limited
Locus Bioscience
Pherecydes Pharma
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bacteriophages Therapy Service Market Size 2018-2029
2.1.2 Bacteriophages Therapy Service Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Bacteriophages Therapy Service Segment by Type
2.2.1 Lytic
2.2.2 lysogenic
2.3 Bacteriophages Therapy Service Market Size by Type
2.3.1 Bacteriophages Therapy Service Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Bacteriophages Therapy Service Market Size Market Share by Type (2018-2023)
2.4 Bacteriophages Therapy Service Segment by Application
2.4.1 Diagnostic
2.4.2 Antimicrobial Drug Discovery
2.4.3 Veterinary medicines
2.5 Bacteriophages Therapy Service Market Size by Application
2.5.1 Bacteriophages Therapy Service Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Bacteriophages Therapy Service Market Size Market Share by Application (2018-2023)
3 Bacteriophages Therapy Service Market Size by Player
3.1 Bacteriophages Therapy Service Market Size Market Share by Players
3.1.1 Global Bacteriophages Therapy Service Revenue by Players (2018-2023)
3.1.2 Global Bacteriophages Therapy Service Revenue Market Share by Players (2018-2023)
3.2 Global Bacteriophages Therapy Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bacteriophages Therapy Service by Regions
4.1 Bacteriophages Therapy Service Market Size by Regions (2018-2023)
4.2 Americas Bacteriophages Therapy Service Market Size Growth (2018-2023)
4.3 APAC Bacteriophages Therapy Service Market Size Growth (2018-2023)
4.4 Europe Bacteriophages Therapy Service Market Size Growth (2018-2023)
4.5 Middle East & Africa Bacteriophages Therapy Service Market Size Growth (2018-2023)
5 Americas
5.1 Americas Bacteriophages Therapy Service Market Size by Country (2018-2023)
5.2 Americas Bacteriophages Therapy Service Market Size by Type (2018-2023)
5.3 Americas Bacteriophages Therapy Service Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bacteriophages Therapy Service Market Size by Region (2018-2023)
6.2 APAC Bacteriophages Therapy Service Market Size by Type (2018-2023)
6.3 APAC Bacteriophages Therapy Service Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bacteriophages Therapy Service by Country (2018-2023)
7.2 Europe Bacteriophages Therapy Service Market Size by Type (2018-2023)
7.3 Europe Bacteriophages Therapy Service Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bacteriophages Therapy Service by Region (2018-2023)
8.2 Middle East & Africa Bacteriophages Therapy Service Market Size by Type (2018-2023)
8.3 Middle East & Africa Bacteriophages Therapy Service Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Bacteriophages Therapy Service Market Forecast
10.1 Global Bacteriophages Therapy Service Forecast by Regions (2024-2029)
10.1.1 Global Bacteriophages Therapy Service Forecast by Regions (2024-2029)
10.1.2 Americas Bacteriophages Therapy Service Forecast
10.1.3 APAC Bacteriophages Therapy Service Forecast
10.1.4 Europe Bacteriophages Therapy Service Forecast
10.1.5 Middle East & Africa Bacteriophages Therapy Service Forecast
10.2 Americas Bacteriophages Therapy Service Forecast by Country (2024-2029)
10.2.1 United States Bacteriophages Therapy Service Market Forecast
10.2.2 Canada Bacteriophages Therapy Service Market Forecast
10.2.3 Mexico Bacteriophages Therapy Service Market Forecast
10.2.4 Brazil Bacteriophages Therapy Service Market Forecast
10.3 APAC Bacteriophages Therapy Service Forecast by Region (2024-2029)
10.3.1 China Bacteriophages Therapy Service Market Forecast
10.3.2 Japan Bacteriophages Therapy Service Market Forecast
10.3.3 Korea Bacteriophages Therapy Service Market Forecast
10.3.4 Southeast Asia Bacteriophages Therapy Service Market Forecast
10.3.5 India Bacteriophages Therapy Service Market Forecast
10.3.6 Australia Bacteriophages Therapy Service Market Forecast
10.4 Europe Bacteriophages Therapy Service Forecast by Country (2024-2029)
10.4.1 Germany Bacteriophages Therapy Service Market Forecast
10.4.2 France Bacteriophages Therapy Service Market Forecast
10.4.3 UK Bacteriophages Therapy Service Market Forecast
10.4.4 Italy Bacteriophages Therapy Service Market Forecast
10.4.5 Russia Bacteriophages Therapy Service Market Forecast
10.5 Middle East & Africa Bacteriophages Therapy Service Forecast by Region (2024-2029)
10.5.1 Egypt Bacteriophages Therapy Service Market Forecast
10.5.2 South Africa Bacteriophages Therapy Service Market Forecast
10.5.3 Israel Bacteriophages Therapy Service Market Forecast
10.5.4 Turkey Bacteriophages Therapy Service Market Forecast
10.5.5 GCC Countries Bacteriophages Therapy Service Market Forecast
10.6 Global Bacteriophages Therapy Service Forecast by Type (2024-2029)
10.7 Global Bacteriophages Therapy Service Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 AmpliPhi Bioscience Corporation
11.1.1 AmpliPhi Bioscience Corporation Company Information
11.1.2 AmpliPhi Bioscience Corporation Bacteriophages Therapy Service Product Offered
11.1.3 AmpliPhi Bioscience Corporation Bacteriophages Therapy Service Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 AmpliPhi Bioscience Corporation Main Business Overview
11.1.5 AmpliPhi Bioscience Corporation Latest Developments
11.2 EnBiotix
11.2.1 EnBiotix Company Information
11.2.2 EnBiotix Bacteriophages Therapy Service Product Offered
11.2.3 EnBiotix Bacteriophages Therapy Service Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 EnBiotix Main Business Overview
11.2.5 EnBiotix Latest Developments
11.3 iNtoDEWorld
11.3.1 iNtoDEWorld Company Information
11.3.2 iNtoDEWorld Bacteriophages Therapy Service Product Offered
11.3.3 iNtoDEWorld Bacteriophages Therapy Service Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 iNtoDEWorld Main Business Overview
11.3.5 iNtoDEWorld Latest Developments
11.4 Phage International
11.4.1 Phage International Company Information
11.4.2 Phage International Bacteriophages Therapy Service Product Offered
11.4.3 Phage International Bacteriophages Therapy Service Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Phage International Main Business Overview
11.4.5 Phage International Latest Developments
11.5 Fixed Phage limited
11.5.1 Fixed Phage limited Company Information
11.5.2 Fixed Phage limited Bacteriophages Therapy Service Product Offered
11.5.3 Fixed Phage limited Bacteriophages Therapy Service Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Fixed Phage limited Main Business Overview
11.5.5 Fixed Phage limited Latest Developments
11.6 Locus Bioscience
11.6.1 Locus Bioscience Company Information
11.6.2 Locus Bioscience Bacteriophages Therapy Service Product Offered
11.6.3 Locus Bioscience Bacteriophages Therapy Service Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Locus Bioscience Main Business Overview
11.6.5 Locus Bioscience Latest Developments
11.7 Pherecydes Pharma
11.7.1 Pherecydes Pharma Company Information
11.7.2 Pherecydes Pharma Bacteriophages Therapy Service Product Offered
11.7.3 Pherecydes Pharma Bacteriophages Therapy Service Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Pherecydes Pharma Main Business Overview
11.7.5 Pherecydes Pharma Latest Developments
12 Research Findings and Conclusion